T cells of patients with myelodysplastic syndrome are frequently derived from the malignant clone

被引:11
|
作者
Vercauteren, Suzanne M. [1 ,2 ,3 ]
Starczynowski, Daniel T. [2 ,3 ]
Sung, Sandy [2 ,3 ]
McNeil, Kelly [4 ]
Salski, Chris [4 ]
Jensen, Clara-Lynn [5 ]
Bruyere, Helene [3 ,5 ]
Lam, Wan L. [3 ,6 ]
Karsan, Aly [2 ,3 ,4 ]
机构
[1] British Columbia Childrens Hosp, Pathol & Lab Med, Vancouver, BC V6H 3V4, Canada
[2] BC Canc Agcy, British Columbia Genome Sci Ctr, Vancouver, BC, Canada
[3] Univ British Columbia, Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada
[4] BC Canc Agcy, Canc Genet Lab, Vancouver, BC, Canada
[5] Vancouver Gen Hosp, Pathol & Lab Med, Vancouver, BC, Canada
[6] British Columbia Canc Agcy, Integrated Oncol Program, Vancouver, BC V5Z 4E6, Canada
关键词
myelodysplastic syndrome; T cell clonality; array; karyotype; ARRAY CGH ANALYSIS; MONOSOMY-7; RESOLUTION; LEUKEMIA; GENE;
D O I
10.1111/j.1365-2141.2011.08872.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:409 / 412
页数:4
相关论文
共 50 条
  • [41] Characterization and targeting of malignant stem cells in patients with advanced myelodysplastic syndromes
    Stevens, Brett M.
    Khan, Nabilah
    D'Alessandro, Angelo
    Nemkov, Travis
    Winters, Amanda
    Jones, Courtney L.
    Zhang, Wei
    Pollyea, Daniel A.
    Jordan, Craig T.
    NATURE COMMUNICATIONS, 2018, 9
  • [42] Gene expression profiling of the bone marrow mononuclear cells from patients with myelodysplastic syndrome
    Qian, J
    Chen, ZX
    Wang, W
    Cen, HN
    Xue, YQ
    ONCOLOGY REPORTS, 2005, 14 (05) : 1189 - 1197
  • [43] Reduced Proteasomal Activity in Marrow Cells From Myelodysplastic Syndrome (MDS) Patients.
    Karabina, Stela
    Thanopoulou, Eleni
    Athanasiou, Sotirios D.
    Symeonidis, Argiris
    Zoumbos, Nicholas
    BLOOD, 2009, 114 (22) : 706 - 707
  • [44] CYTOKINETIC ANALYSIS OF CELLS DERIVED FROM PATIENTS WITH WERNER SYNDROME
    NIKAIDO, O
    SHIMA, A
    JOURNAL OF RADIATION RESEARCH, 1982, 23 (01) : 40 - 40
  • [45] Circulating cancer giant cells with unique characteristics frequently found in patients with myelodysplastic syndromes (MDS)
    Ali, Abdullah Mahmood
    BenMohamed, Fatima
    Decina, Alessandra
    Mukherjee, Sanjay
    Levi, Shelley
    Castillo, Laura Nalleli Garrido
    Brechot, Davide
    Jurcic, Joseph
    Raza, Azra
    Brechot, Patrizia Paterlini
    MEDICAL ONCOLOGY, 2023, 40 (07)
  • [46] Circulating cancer giant cells with unique characteristics frequently found in patients with myelodysplastic syndromes (MDS)
    Abdullah Mahmood Ali
    Fatima BenMohamed
    Alessandra Decina
    Sanjay Mukherjee
    Shelley Levi
    Laura Nalleli Garrido Castillo
    Davide Bréchot
    Joseph Jurcic
    Azra Raza
    Patrizia Paterlini Bréchot
    Medical Oncology, 40
  • [47] Clone specific in situ hybridization for preparation of malignant cells in cutaneous T cell lymphoma
    Lukowsky, A
    Schreiber, K
    Nuernberg, W
    Henning, U
    Sterry, W
    Muche, JM
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (03) : 792 - 792
  • [48] 5-Azacytidine Specifically Depletes Regulatory T Cells (Tregs) in Myelodysplastic Syndrome (MDS) Patients
    Costantini, Benedetta
    Kordasti, Shahram Y.
    Kulasekataraj, Austin G.
    Jiang, Jie
    Seidl, Thomas
    Abellan, Pilar Perez
    Hayden, Janet
    Farzaneh, Farzin
    Mufti, Ghulam J.
    BLOOD, 2011, 118 (21) : 358 - 358
  • [49] QUANTITATIVE SYSTEM FOR ASSAY OF MALIGNANT TRANSFORMATION BY CHEMICAL CARCINOGENS USING A CLONE DERIVED FROM BALB/3T3
    KAKUNAGA, T
    INTERNATIONAL JOURNAL OF CANCER, 1973, 12 (02) : 463 - 473
  • [50] The Quality and Quantity of Leukemia-derived Dendritic Cells From Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome Are a Predictive Factor for the Lytic Potential of Dendritic Cells-primed Leukemia-Specific T Cells
    Grabrucker, Christine
    Liepert, Anja
    Dreyssig, Julia
    Kremser, Andreas
    Kroell, Tanja
    Freudenreich, Markus
    Schmid, Christoph
    Schweiger, Cornelia
    Tischer, Johanna
    Kolb, Hans-Jochen
    Schmetzer, Helga
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (05) : 523 - 537